Literature DB >> 26386926

Addition of ivabradine to betablockers in patients with atrial fibrillation: Effects on heart rate and exercise tolerance.

Giuseppe Caminiti1, Chiara Fossati2, Giuseppe Rosano2, Maurizio Volterrani2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26386926     DOI: 10.1016/j.ijcard.2015.08.207

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  5 in total

1.  Ivabradine in heart failure patients with reduced ejection fraction and history of paroxysmal atrial fibrillation.

Authors:  Yu-Sheng Lin; Jeng-Yu Jan; Jung-Jung Chang; Ming-Shyan Lin; Teng-Yao Yang; Po-Chang Wang; Mien-Cheng Chen
Journal:  ESC Heart Fail       Date:  2022-05-12

Review 2.  Emerging role of ivabradine for rate control in atrial fibrillation.

Authors:  Sarah L Turley; Kerry E Francis; Denise K Lowe; William D Cahoon
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-09-22

3.  A case report of ivabradine used for heart rate control of atrial fibrillation in acute decompensated heart failure.

Authors:  Edward Hardison; Zachary L Cox; Katherine Heckman; Patricia A Kelly; JoAnn Lindenfeld
Journal:  Eur Heart J Case Rep       Date:  2022-02-17

4.  Cardiac pacemaker channel (HCN4) inhibition and atrial arrhythmogenesis after releasing cardiac sympathetic activation.

Authors:  Kristine Chobanyan-Jürgens; Karsten Heusser; David Duncker; Christian Veltmann; Marcus May; Heidrun Mehling; Friedrich C Luft; Christoph Schröder; Jens Jordan; Jens Tank
Journal:  Sci Rep       Date:  2018-05-17       Impact factor: 4.379

5.  Effect of induced chronic atrial fibrillation on exercise performance in Standardbred trotters.

Authors:  Rikke Buhl; Helena Carstensen; Eva Zander Hesselkilde; Bjørg Zinkernagel Klein; Karen Margrethe Hougaard; Kirsten Bomberg Ravn; Ameli Victoria Loft-Andersen; Merle Friederike Fenner; Christian Pipper; Thomas Jespersen
Journal:  J Vet Intern Med       Date:  2018-05-10       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.